Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 10
Submit an article Journal homepage
1,207
Views
13
CrossRef citations to date
0
Altmetric
Oncology

Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective

Bhuvana SagarCigna Health and Life Insurance Company, Plano, TX, USA;
,
Yu Shen LinCigna Health and Life Insurance Company, Philadelphia, PA, USA;
&
Liana D. CastelCigna Health and Life Insurance Company, Bloomfield, CT, USA; ;University of Mount Olive Tillman School of Business, Mount Olive, NC, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-1221-2441
ORCID Icon
Pages 1018-1023 | Received 15 Mar 2017, Accepted 29 May 2017, Published online: 03 Jul 2017

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

E. Feletto, P. Grogan, A. Vassallo & K. Canfell. (2019) Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example. Climacteric 22:6, pages 538-543.
Read now

Articles from other publishers (12)

Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari & Ramin Ravangard. (2023) Economic burden of breast cancer: a case of Southern Iran. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Nikki McCaffrey, Seong Leang Cheah, Tim Luckett, Jane L. Phillips, Meera Agar, Patricia M. Davidson, Frances Boyle, Tim Shaw, David C. Currow & Melanie Lovell. (2023) Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial. PLOS ONE 18:2, pages e0282465.
Crossref
Russell F. Palm, Kurt G. Eicher, Austin J. Sim, Susan Peneguy, Stephen A. Rosenberg, Stuart Wasserman & Peter A. S. Johnstone. (2021) Assessment of MRI-Linac Economics under the RO-APM. Journal of Clinical Medicine 10:20, pages 4706.
Crossref
Matthias Dietzel, Paola Clauser, Panagiotis Kapetas, Rüdiger Schulz-Wendtland & Pascal Andreas Thomas Baltzer. (2021) Images Are Data: A Breast Imaging Perspective on a Contemporary Paradigm. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 193:08, pages 898-908.
Crossref
Liangyuan Hu, Lihua Li, Jiayi Ji & Mark Sanderson. (2020) Identifying and understanding determinants of high healthcare costs for breast cancer: a quantile regression machine learning approach. BMC Health Services Research 20:1.
Crossref
Shao-Yi Huang, Ho-Min Chen, Kai-Hsin Liao, Bor-Sheng Ko & Fei-Yuan Hsiao. (2020) Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017. BMJ Open 10:10, pages e036341.
Crossref
Ankush Chandra, Jacob S. Young, Cecilia Dalle Ore, Fara Dayani, Darryl Lau, Harsh Wadhwa, Jonathan W. Rick, Alan T. Nguyen, Michael W. McDermott, Mitchel S. Berger & Manish K. Aghi. (2020) Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma. Journal of Neurosurgery 133:1, pages 89-99.
Crossref
Jesse A. Sussell, Daniel Sheinson, Ning Wu, Bijal Shah-Manek & Arpamas Seetasith. (2020) HER2-Positive Metastatic Breast Cancer: A Retrospective Cohort Study of Healthcare Costs in the Targeted-Therapy Age. Advances in Therapy 37:4, pages 1632-1645.
Crossref
Delphine Héquet, Cyrille Huchon, Anne-Laure Soilly, Bernard Asselain, Helene Berseneff, Caroline Trichot, Aline Combes, Karine Alves, Thuy Nguyen, Roman Rouzier & Sandrine Baffert. (2019) Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study. PLOS ONE 14:7, pages e0210917.
Crossref
Debra P. Ritzwoller, Paul A. Fishman, Matthew P. Banegas, Nikki M. Carroll, Maureen O'Keeffe‐Rosetti, Angel M. Cronin, Hajime Uno, Mark C. Hornbrook & Michael J. Hassett. (2018) Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis . Health Services Research 53:6, pages 5106-5128.
Crossref
Ricky McCullough. (2018) Merit-based Claim Adjudication for Cancer Treatment Toxicities – Policy Trends that Lower Downstream Costs. Journal of Insurance Medicine 47:4, pages 236-248.
Crossref
Deborah R. Kaye, Hye Sung Min, Lindsey A. Herrel, James M. Dupree, Chad Ellimoottil & David C. Miller. (2018) Costs of Cancer Care Across the Disease Continuum. The Oncologist 23:7, pages 798-805.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.